Position in GILD
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$8,426,246
-$4,079,563 QoQ
Shares Held
66,695
-25.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#462
of 2,266 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Beacon Pointe Advisors, LLC holds $381,609,244 across 14 Drug Manufacturers - General names. GILD ranks #10 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
365,648 | $92,863,622 | |
| 2 | LLY |
ELI LILLY & Co
|
61,241 | $73,454,298 | |
| 3 | ABBV |
AbbVie Inc.
|
195,761 | $49,261,298 | |
| 4 | MRK |
Merck & Co., Inc.
|
363,066 | $46,653,981 | |
| 5 | AMGN |
Amgen Inc
|
108,053 | $39,128,152 | |
| 6 | PFE |
Pfizer Inc
|
1,161,607 | $27,971,496 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
232,697 | $13,408,001 | |
| 8 | NVS |
Novartis AG
|
84,234 | $13,201,152 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,426,246 | 66,695 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $12,505,809 | 89,731 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,193,557 | 83,050 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $3,602,172 | 32,452 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,978,348 | 35,883 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,960,295 | 35,344 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,442,814 | 37,272 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,522,453 | 42,014 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,592,007 | 52,354 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,964,583 | 54,124 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $5,089,048 | 62,820 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $4,794,960 | 63,984 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,044,804 | 39,507 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,418,899 | 53,259 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,605,013 | 41,992 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,161,864 | 35,044 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,050,855 | 33,180 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,749,154 | 63,064 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $2,474,040 | 34,073 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,025,789 | 29,002 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,680,184 | 24,400 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $228,531 | 3,536 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $265,432 | 4,556 | Shares | Sole | 2021-02-12 | |
| 2020-06-30 | $357,078 | 4,641 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||